S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.23%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.10%) $2 349.60
Silver
(-0.07%) $27.52
Platinum
(0.25%) $924.40
USD/EUR
(0.34%) $0.935
USD/NOK
(0.56%) $11.01
USD/GBP
(0.12%) $0.800
USD/RUB
(0.00%) $92.17

Sanntidsoppdatering for Bio-Techne Corp [TECH]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 6.71%

BUY
66.00%
return 7.08%
SELL
34.69%
return 13.98%
Sist oppdatert26 apr 2024 @ 22:00

2.23% $ 64.06

SELG 3129 min ago

@ $64.15

Utstedt: 26 apr 2024 @ 19:48


Avkastning: -0.14%


Forrige signal: apr 25 - 21:50


Forrige signal: Kjøp


Avkastning: 2.40 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):
Profile picture for Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide...

Stats
Dagens volum 946 213
Gjennomsnittsvolum 1.09M
Markedsverdi 10.07B
EPS $0 ( 2024-02-01 )
Neste inntjeningsdato ( $0.460 ) 2024-05-01
Last Dividend $0.0800 ( 2023-11-09 )
Next Dividend $0 ( N/A )
P/E 46.09
ATR14 $1.869 (2.91%)
Insider Trading
Date Person Action Amount type
2024-04-03 Bohnen Shane Sell 2 259 Restricted Stock Units
2024-04-03 Bohnen Shane Buy 2 259 Common Stock
2024-04-03 Bohnen Shane Sell 747 Common Stock
2024-03-07 Nusse Roeland Sell 10 400 Common Stock
2024-02-01 Geist William Sell 1 111 Common Stock
INSIDER POWER
3.66
Last 99 transactions
Buy: 1 979 464 | Sell: 2 067 622

Volum Korrelasjon

Lang: -0.73 (moderate negative)
Kort: 0.92 (very strong)
Signal:(44) Expect same movement, but be aware

Bio-Techne Corp Korrelasjon

10 Mest positive korrelasjoner
MMAC0.917
NETE0.912
LWAC0.887
SRAC0.86
AMRB0.854
BLI0.815
10 Mest negative korrelasjoner
SVAC-0.935
TLGT-0.901
RMRM-0.897
PAIC-0.887
FEYE-0.864
SVOK-0.851
TEAM-0.842
UBOH-0.834
TRIN-0.833
INZY-0.827

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bio-Techne Corp Korrelasjon - Valuta/Råvare

The country flag 0.29
( neutral )
The country flag 0.45
( neutral )
The country flag 0.00
( neutral )
The country flag 0.54
( weak )
The country flag 0.21
( neutral )
The country flag -0.45
( neutral )

Bio-Techne Corp Økonomi

Annual 2023
Omsetning: $1.14B
Bruttogevinst: $769.82M (67.72 %)
EPS: $1.810
FY 2023
Omsetning: $1.14B
Bruttogevinst: $769.82M (67.72 %)
EPS: $1.810
FY 2022
Omsetning: $1.11B
Bruttogevinst: $756.50M (68.42 %)
EPS: $1.730
FY 2021
Omsetning: $931.03M
Bruttogevinst: $632.85M (67.97 %)
EPS: $0.867

Financial Reports:

No articles found.

Bio-Techne Corp Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Bio-Techne Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.04 - Stable (20.74%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0625 2008-10-30
Last Dividend $0.0800 2023-11-09
Next Dividend $0 N/A
Payout Date 2023-11-24
Next Payout Date N/A
# dividends 61 --
Total Paid Out $4.63 --
Avg. Dividend % Per Year 0.25% --
Score 4.89 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.04
Div. Directional Score 8.94 --
Next Divdend (Est)
(2024-07-01)
$0.0812 Estimate 39.51 %
Dividend Stability
0.79 Good
Dividend Score
4.89
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2008 $0.0625 0.37%
2009 $0.253 1.57%
2010 $0.263 1.53%
2011 $0.273 1.64%
2012 $0.285 1.66%
2013 $0.303 1.75%
2014 $0.313 1.33%
2015 $0.320 1.40%
2016 $0.320 1.45%
2017 $0.320 1.25%
2018 $0.320 0.97%
2019 $0.320 0.90%
2020 $0.320 0.58%
2021 $0.320 0.41%
2022 $0.320 0.26%
2023 $0.320 0.39%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1961.5006.089.13[0 - 0.5]
returnOnAssetsTTM0.08211.2007.268.72[0 - 0.3]
returnOnEquityTTM0.1151.5009.8410.00[0.1 - 1]
payoutRatioTTM0.225-1.0007.75-7.75[0 - 1]
currentRatioTTM4.370.80010.008.00[1 - 3]
quickRatioTTM2.540.80010.008.00[0.8 - 2.5]
cashRatioTTM0.9621.5005.778.65[0.2 - 2]
debtRatioTTM0.203-1.5006.61-9.91[0 - 0.6]
interestCoverageTTM20.761.0003.423.42[3 - 30]
operatingCashFlowPerShareTTM1.7552.009.4210.00[0 - 30]
freeCashFlowPerShareTTM1.4312.009.2810.00[0 - 20]
debtEquityRatioTTM0.283-1.5008.87-10.00[0 - 2.5]
grossProfitMarginTTM0.6711.0002.152.15[0.2 - 0.8]
operatingProfitMarginTTM0.2351.0007.317.31[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4971.0008.358.35[0.2 - 2]
assetTurnoverTTM0.4190.800-0.538-0.430[0.5 - 2]
Total Score11.84

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM45.021.0005.550[1 - 100]
returnOnEquityTTM0.1152.509.9010.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.4312.009.5210.00[0 - 30]
dividendYielPercentageTTM0.5001.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.7552.009.4210.00[0 - 30]
payoutRatioTTM0.2251.5007.75-7.75[0 - 1]
pegRatioTTM0.3351.500-1.1000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2411.0006.460[0.1 - 0.5]
Total Score6.04

Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.